Navigating Drug Pricing Challenges

This chapter explores the complexities of drug pricing in the U.S., highlighting the impact of the patent system and potential reforms, including the German pricing model. It examines the tension between pharmaceutical profitability and accessibility, while discussing historical instances and the need for political will to implement meaningful changes.